Elite Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$14.1M Buy
+89,272
New +$14.1M 2.7% 8
2020
Q1
– Sell
-6,878
Closed -$654K – 42
2019
Q4
$654K Sell
6,878
-53
-0.8% -$4.58K 0.37% 18
2019
Q3
$528K Sell
6,931
-483
-7% -$40.1K 0.73% 19
2019
Q2
$650K Sell
7,414
-531
-7% -$45.3K 0.88% 15
2019
Q1
$719K Sell
7,945
-1,120
-12% -$95.3K 1.33% 15
2018
Q4
$650K Buy
9,065
+160
+2% +$12.9K 0.63% 32
2018
Q3
$854K Sell
8,905
-23
-0.3% -$2.23K 0.18% 33
2018
Q2
$850K Buy
8,928
+459
+5% +$42.2K 0.3% 32
2018
Q1
$743K Buy
8,469
+244
+3% +$22.3K 0.61% 35
2017
Q4
$698K Buy
+8,225
New +$689K 0.59% 37
2016
Q3
$796K Sell
12,012
-2,791
-19% -$173K 1.3% 22
2016
Q2
$800K Sell
14,803
-2,831
-16% -$155K 1.32% 24
2016
Q1
$910K Buy
17,634
+1,509
+9% +$78.4K 1.28% 23
2015
Q4
$1.13M Buy
16,125
+5,097
+46% +$348K 1.68% 20
2015
Q3
$686K Sell
11,028
-3,762
-25% -$296K 1.08% 39
2015
Q2
$1.24M Sell
14,790
-2,037
-12% -$158K 1.29% 27
2015
Q1
$1.26M Buy
+16,827
New +$1.18M 1.12% 33

Other funds holding XBI

Elite Wealth Management's XBI Position: Q3 2026 in Review

Elite Wealth Management opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q3 2026: 89,272 shares worth $14.1M. The stake represents 2.7% of the portfolio and ranks #8 among its holdings. This is a return to the name: Elite Wealth Management previously reported a position in XBI as recently as Q4 2019.

Elite Wealth Management first reported a position in XBI in Q1 2015 and has held it in 17 quarters since. 962 funds tracked by Wall St. Rank hold XBI as of Q3 2026.

  • Elite Wealth Management held 89,272 shares of State Street SPDR S&P Biotech ETF worth $14.1M as of Q3 2026.
  • State Street SPDR S&P Biotech ETF was a new Elite Wealth Management position in Q3 2026.
  • State Street SPDR S&P Biotech ETF made up 2.7% of Elite Wealth Management's portfolio in Q3 2026, its #8 holding.
  • Elite Wealth Management first reported a position in State Street SPDR S&P Biotech ETF in Q1 2015 and has held it in 17 quarters since.
  • 962 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.

Based on Elite Wealth Management's 13F filing for Q3 2026, filed 3 Nov 2026.